|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Profit before taxation | |||||
| Net interest expense | |||||
| Depreciation, amortisation and impairment | |||||
| Loss on disposal of property, plant and equipment and intangible assets | |||||
| Share-based payments expense (equity-settled) | |||||
| Share of results of associates | |||||
| Gain on disposal of interest in associate | |||||
| Pension costs less cash paid | |||||
| Decrease/(increase) in inventories | |||||
| Increase in trade and other receivables | |||||
| Increase/(decrease) in trade and other payables and provisions | |||||
| Cash generated from operations | |||||
| Interest received | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Net cash inflow from operating activities | |||||
| Cash flows from investing activities | |||||
| Acquisitions, net of cash acquired | |||||
| Capital expenditure | |||||
| Purchase of investments | |||||
| Proceeds from disposal of property, plant and equipment | |||||
| Investment in associate | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Purchase of own shares | |||||
| Proceeds from own shares | |||||
| Payment of capital element of lease liabilities | |||||
| Proceeds from borrowings due within one year | |||||
| Settlement of borrowings due within one year | |||||
| Proceeds from borrowings due after one year | |||||
| Settlement of borrowings due after one year | |||||
| Settlement of currency swaps | |||||
| Equity dividends paid | |||||
| Net cash used in financing activities | |||||
| Net (decrease)/increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Exchange adjustments | |||||
| Restructuring and rationalisation expenses | |||||
| Acquisition-related costs | |||||
| Legal and other costs | |||||
| Bank overdrafts | |||||
| Cash and cash equivalents at end of year | |||||
Loading...